The latest move is set to cut costs of starting oral doses of GLP-1s to as low as around $150 for certain groups of people once approved, a senior US official said.

xWASHINGTON: US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs.

Both companies “have agreed to offer their most popular GLP-1 weight-loss drug,” Trump said at the White House, “at drastic discounts.””Eli Lilly and Novo Nordisk are committing to offer Zepbound and Wegovy at 'Most Favored Nation' rates for American patients,” Trump added, saying this would lower the costs of products for those eligible.

During the announcement event in the Oval Office, a company represent

See Full Page